CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 12 No. 8
 

Moffitt Center "Prospered by Learning to Live With Managed Care"

August 1, 1998

Athough managed care represents a major change from the way many cancer centers have traditionallydone business, it is "here to stay," says Patricia J. Goldsmith, vice president for managed care and business development at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. Addressing the 24th Annual National Meeting of the Association of Community Cancer Centers, she added that Moffitt’s experience teaches that "we can prosper" if we "learn to live with it." In 3 years, Moffitt changed adversarial relationships with managed care companies, which accounted for a small percentage of its patients, into a rapidly growing economic mainstay, which will soon provide almost half of the center’s business.

In 1995, Moffitt, which is Florida’s only National Cancer Institute (NCI)-designated cancer center, had nine managed care contracts representing 16% of its business, Goldsmith noted. By 1998, 38 managed care contracts provide 40% of the business, a figure projected to reach 47% in 1999.

With an overall total 4,000 admissions per year to its 162 beds and over 115,000 outpatient visits in 1996, Moffitt has found the increasing numbers of patients flowing from managed care a key to its financial stability and prospects. In place of the "significant access issues" and hostility that used to discourage managed care patients from seeking care at the center, Moffitt has undergone a "big attitude change" as it successfully adapted to managed care without compromising its standards of care. And, Goldsmith believes, other centers can do the same.

Four Crucial Steps

She outlined four steps that proved crucial to the turn-around. First, Moffitt "built a managed care infrastructure" to effectively handle the plans’ bureaucratic requirements. Second, it "developed a managed care philosophy" that embraces both financial and patient-care concerns. The managed care department, she noted "reports to both clinical and financial" leadership. Third, it instituted "ongoing employee and physician education on managed care" issues and concerns. Fourth, it created "meaningful interaction between managed care and Moffitt leadership."

A basic lesson of this experience is that "educating and developing relationships is worth the effort," Goldsmith went on. Moffitt makes a practice of inviting case managers and other managed care officials for on-site orientations and tours of the center’s facilities. It also brings educational programs to managed care officials at their regional meetings. Both strategies allow members of the two organizations to meet as human beings and forge personal ties.

Case managers are particularly crucial in the success of Moffitt’s relationship with a managed care company because they are "key drivers of where oncology care [patients] go, "she said. "The more that case managers understand oncology care" she added, "the less you are likely to be questioned" about treatments. In educating managed care officials, it is important to "show expertise in all areas" and that "physicians...be involved in negotiations" and tours. And, she added, key to developing successful relationships is a simple rule: "Always feed people." Breaking bread together greatly speeds up developing human relationships.

During negotiations, it’s important not to rush, and to first "sell your product"--the capabilities of your institution--and "then discuss price." Remember, she added, that each action or decision sets a precedent for the future.

Careful Documentation, Presentation of Data

Presenting a full view of a cancer center requires careful documentation in many areas, including case mix index, length of stays, outcomes, patient satisfaction, types of patients referred to you, and payment issues. Full justification of your costs and charges is very important "because managed care organizations are more used to negotiating with full-range community hospitals" than with cancer centers and are used to paying lower per diems and more flat rate outpatient payments than is customary at a cancer center. It is necessary to educate managed care companies on "why oncology care is different" from other types of care.

Through careful presentation of data, however, Goldsmith said, Moffitt succeeded in showing that, although its day rate was higher than that of community hospitals, its rate of intensive care unit bed days was lower than rates for comparable patients elsewhere, and therefore that Moffitt provided more cost-economical care. "Pharmaceuticals present a major issue for oncology," however, that "needs lots of education" for managed care organizations.

These strategies have resulted in "success stories" at Moffitt, including a large bone marrow transplant business, which used to be transferred to centers out of state, and very good outcomes data. A major local advertising campaign also informed the public about Moffitt’s staff and facilities and urged them to "make sure Moffitt is in your plan." This convinced local employers to ask that Moffitt be added to their employee plans and resulted in increased referrals, Goldsmith said.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 48-Year-Old Woman With Irregular Vaginal Bleeding
Brian Morse, MD1 , June 10, 2013

A 48-year-old female presents with complaints of irregular vaginal bleeding and postcoital bleeding. Images from a PET/CT and pelvis MRI reveal characteristic findings. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Soluble HER2 Levels Prognostic Factor in HER2+ Breast Cancer
  • ASCO: PD-L1 Antibody Elicits Durable Response in RCC
  • RECORD-3: Sunitinib Still Standard First-Line Treatment in Metastatic RCC
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • Radiation-Induced Enteritis: Incidence, Mechanisms, and Management
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy